Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.3 USD | +0.09% | -5.20% | -7.76% |
May. 22 | Kalvista Pharmaceuticals Insider Sold Shares Worth $258,337, According to a Recent SEC Filing | MT |
Apr. 22 | Kalvista Pharmaceuticals, Inc. Appoints William C. Fairey to the Board of Directors | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.76% | 477M | |
-2.30% | 90.02B | |
-1.18% | 39.15B | |
-15.83% | 31.71B | |
+62.86% | 26.47B | |
-21.68% | 14.34B | |
-8.73% | 12.89B | |
-15.05% | 11.18B | |
-45.69% | 10.97B | |
+4.94% | 8.94B |
- Stock Market
- Equities
- KALV Stock
- News KalVista Pharmaceuticals, Inc.
- KalVista Pharmaceuticals : SVB Leerink Adjusts KalVista Pharmaceuticals' Price Target to $39 From $28, Keeps at Outperform